Break02:30 PM

10:30 AM

Tuesday, 18th May | Time Zone - EDT

Industry Roundtable

Co-Chaired by:Bibhash Mukhopadhyay, IndependentRoger Longman, Co-Founder & Chairman, Real Endpoints LLC

Panelists:Denis Patrick, VP, Head of Partnering Innovation, Managing Partner, P�zer VenturesLore Gruenbaum, Vice President, Therapy Acceleration Program, The Leukemia & Lymphoma SocietyOtello Stampacchia, Managing Director, Omega Fund Management, LLCPhilippe Lopes-Fernandes, Executive Vice President, CBO, Ipsen

Day 1 Opens09:40 AM

Welcome Speech by the Host10:10 AM

Introductory Speech by Roger Longman, Co-Founder & Chairman, Real Endpoints LLC 10:15 AM

11:30 AM

Pharma-Bio DealMaking: M&A and Partnering Panel

Co-Chaired by:Michael Kingston, Managing Director & Co-Head of North America Life Sciences, Lazard Ltd.Peter Sandor, SVP, PFL Oncology, Astellas Pharma, Inc.

Panelists:Chris Sheldon, Vice President & Head of Oncology Business Development & Licensing, AstraZenecaDamien Chopy, Business Development, Director, F. Ho�mann-La Roche Ltd.Niels Emmerich, VP, Global Head Search & Evaluation, AbbVie, Inc.Patrick Tricoli, CEO of Nanobiotix USA & EVP, Global Head of BD, Nanobiotix Corp.Phil L’Huillier, Head of European Business Development, MSD

Virtual Lunch Break12:20 PM

Fireside Chat with Patrick Tricoli, CEO of Nanobiotix USA & EVP, Global Head of BD, Nanobiotix Corp.moderated by Je�rey Bockman, EVP, Head of Oncology Practice, Cello Health BioConsulting

12:50 PM

01:10 PM

Development Strategies for Current Times Panel

Co-Chaired by:Esteban Pombo-Villar, CEO, TargImmune Therapeutics AGMatthias Müllenbeck, SVP, Head Global BD & Alliance Management, Merck KGaA Panelists:Aram Mangasarian, CEO, NOXXON Pharma NVJuergen Gamer, VP Business & Corporate Development, Apogenix AGPeter Llewellyn-Davies, CEO & CFO, APEIRON Biologics AGRay Takigiku, Co-Founder, President & CEO, Bexion Pharmaceuticals, Inc.Richard Godfrey, CEO, BerGenBio ASAScott Wieland, Executive Vice President, Development, Nanobiotix Corp.

Spotlight Showcases

BerGenBio ASA02:10 PM

Supporters:Silver Sponsors:

04:20 PM

Early-Stage Innovation Panel

Co-Chaired by:Kuldeep Neote, VP External Innovation, Eli Lilly and CompanyMichal Preminger, Head, Johnson & Johnson Innovation, East North America, Johnson & Johnson Innovation LLC

Panelists:Althea Stillman, Associate Director, IP Group, Inc.Anton Xavier, Director for Startup Life Science Banking, Silicon Valley BankKate Strayer-Benton, Senior Director of Business Development, Dana-Farber Cancer InstituteMeredith Fisher, Partner, Mass General Brigham VenturesRyan Schoenfeld, Chief Scienti�c O�cer, The Mark Foundation for Cancer Research

End of Day05:10 PM

Day 1 Opens02:50 PM

03:30 PM

Tuesday, 18th May | Time Zone - EDT

Investor Panel

Co-Chaired by:Boris Peaker, Managing Director & Senior Research Analyst, Cowen, Inc.Steve Dickman, CEO, CBT Advisors

Panelists:Alain Thibault, Principal, TVM Life Science Management GmbHJohn Gustofson, Managing Director, AbbVie VenturesPriyanka Belawat, Investment Advisor Private Equity, HBM Partners AGShinichiro Fuse, Managing Director, MPM Capital, Inc.

Break02:30 PM

Keynote: “Next Generation Immunotherapy” by Holger Kissel, Vice President Business Alliances, BioNTech SE 03:10 PM

Supporters:Silver Sponsors:

Wednesday, 19th May | Time Zone - EDT

Day 2 Opens09:40 AM

Welcome Speech by the Host10:05 AM

End of Day04:00 PM

11:10 AM

Investing in Biologics Panel

Chaired by:Michael Rice, Principal, Head of Advanced Therapeutics, Cello Health BioConsulting

Panelists:Eliot Forster, CEO & President, F-star Biotechnology Ltd.Kris Elverum, SVP, Business Development & Strategy, Rubius Therapeutics, Inc.Lisa Decker, CBO, IGM Biosciences, Inc.Nanna Luneborg, Partner, Novo Holdings A/S Rachael Lester, Vice President Corporate Development, Harpoon Therapeutics, Inc.

Virtual Lunch Break12:00 PM

10:10 AM

Precision Medicine in IO Panel

Chaired by:Bob Silverman, CBO, Alloy Therapeutics, Inc.

Panelists:Gerald Batist, Chief Medical O�cer, Exactis InnovationHoward Fingert, Principal Consultant, Howard J. Fingert MD Consulting Je�rey J. Molldrem, Professor and Chair, Hematopoietic Biology and Malignancy, Executive Director ECLIPSE Platform, MD Anderson Cancer CenterJennifer Buell, President & COO, Agenus, Inc.John McAuli�e, Senior Director, Pharma Partnering, Roche DiagnosticsNiranjan Sardesai, Founder, President & CEO, Geneos Therapeutics

Keynote: “Tumor In�ltrating Lymphocyte Cell Therapy for Treatment of Solid Tumors” by Maria Fardis, President & CEO, Iovance Biotherapeutics, Inc. 12:30 PM

Phosplatin Therapeutics Inc.02:10 PM

Break02:30 PM

12:50 PM

Latest Advances in Cell & Gene Therapies Panel

Co-Chaired by:Axel Hoos, SVP, R&D Governance Chair & Therapeutic Area (TA) Head for Oncology, GlaxoSmithKlineBenjamin Burnett, Equity Research Analyst, Stifel Financial Corp. Panelists:Daniel Teper, Co-Founder, Chairman & CEO, Cytovia Therapeutics Inc.Heinz Lubenau, Co-Founder & CEO, VAXIMMJing Zhao, CBO, Refuge Biotechnologies, Inc.Michael Klichinsky, Co-Founder & SVP, Research, Carisma Therapeutics Inc.Mythili Koneru, Chief Medical O�cer, Marker Therapeutics, Inc.Sidharth Kerkar, VP, R&D Oncology, EXUMA Biotechnology

Marker Therapeutics, Inc.01:50 PM

Supporters:Silver Sponsors:

Spotlight Showcases

Break02:30 PM

Wednesday, 19th May | Time Zone - EDT

End of Day04:10 PM

Supporters:Silver Sponsors:

02:50 PM

Cancer Vaccines, Neo Antigens & Related Modalities Panel

Chaired by:Je�rey Bockman, EVP, Head of Oncology Practice, Cello Health BioConsulting Panelists:Andrew Allen, Co-Founder, President & CEO, Gritstone Oncology, Inc.Carlos de Sousa, CEO, Ultimovacs ASAFrederic Ors, CEO, IMV Inc.Mike Mulqueen, VP of Business Development, eTheRNA immunotherapies NVNicolas Poirier, Chief Scienti�c O�cer, OSE Immunotherapeutics

Cytovia Therapeutics Inc.03:50 PM

Thursday, 20th May | Time Zone - EDT

Day 3 Opens10:00 AM

Welcome Speech by the Host10:25 AM

11:30 AM

China Capital in Global Markets Panel

Co-Chaired by:Brad Loncar, CEO, Loncar Investments, LLC Marietta Wu, Managing Director, Quan Capital

Panelists:Amy Tang, Venture Partner, Qiming Venture PartnersMichael Keyoung, Managing Director & Head of North America, CBC Group (C-Bridge Capital) Sean Zhang, Vice President, Lilly Asia VenturesSimone Song, Founder & Senior Partner, ORI Capital LimitedXavier Xie, Partner, YUNION Healthcare Ventures

10:30 AM

Chinese Innovation in IO Panel

Chaired by:Helen Chen, Greater China Managing Partner & Head of China Life Sciences, L.E.K. Consulting

Panelists:Dewan Zeng, Executive Director, Head of Search & Evaluation, BeiGene Ltd.Weiyong Sun, Chief Business O�cer, Hansoh BioWilliam Cao, Founder, Chairman & CEO, Gracell Biotechnologies

Virtual Lunch Break12:20 PM

Spotlight Showcase: Ultimovacs ASA01:00 PM

End of the Forum01:20 PM

Supporters:Silver Sponsors:

Keynote: “What to Look for at ASCO?” by Paul Rennert, President & CSO, Aleta Biotherapeutics 12:40 PM